A combination of stem cells and an extracellular matrix agent as a new therapeutic strategy for ischemic stroke
Yacine Khelif(Centre National de la Recherche Scientifique), Myriam Bernaudin(Centre National de la Recherche Scientifique), Dulce Papy-García(Université Paris-Est Créteil), Jérôme Toutain(Centre National de la Recherche Scientifique), Rozenn Le Gal(Cyceron), Denis Barritault(Délégation Paris 7), Jérôme Levallet(Cyceron), Xavier Laffray(Centre National de la Recherche Scientifique), Quittet, Christine Brunaud(Cyceron), C Renoult(Cyceron), O Touzani(Imagerie et Stratégies Thérapeutiques pour les Cancers et Tissus cérébraux), Laurent Chazalviel(Cyceron)
HAL (Le Centre pour la Communication Scientifique Directe)
June 23, 2019
Cited by 0
Related Papers
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
|Proceedings of the National Academy of Sciences|2013|864
Heparan Sulfate Is a Cellular Receptor for Purified Infectious Prions
|Journal of Biological Chemistry|2005|175
The 37‐kDa/67‐kDa Laminin Receptor Acts as a Receptor for Infectious Prions and Is Inhibited by Polysulfated Glycanes
|The Journal of Infectious Diseases|2006|126
Repurposing doxycycline for synucleinopathies: remodelling of α-synuclein oligomers towards non-toxic parallel beta-sheet structured species
|Scientific Reports|2017|120
Elastin-like recombinamers-based hydrogel modulates post-ischemic remodeling in a non-transmural myocardial infarction in sheep
|Science Translational Medicine|2021|100